VERA · Vera Therapeutics Inc
United States · RS rating 53 · As of 2026-11-03
| Price | 30.71 USD |
|---|---|
| 1-day change | +1.5% |
| RS rating (overall / 1M / 3M / 12M) | 53 / 66 / 69 / 58 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 25 / 11 / 29 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +10.1% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +44.8% |
| Market cap (USD) | $2.8B |